The flavonoid, naringenin, decreases adipose tissue mass and attenuates ovariectomy-associated metabolic disturbances in mice

OBJECTIVE: Adverse metabolic changes associated with loss of ovarian function increase the risk of developing metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) in postmenopausal women. Naringenin improves metabolic disturbances in vitro and in vivo. In the present study, we tested the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Jia-Yu, Kliewer, Kara L, Hamad, Essam M, Cole, Rachel M, Powell, Kimerly A, Andridge, Rebecca R, Straka, Shana R, Yee, Lisa D, Belury, Martha A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350282/
https://www.ncbi.nlm.nih.gov/pubmed/25745505
http://dx.doi.org/10.1186/1743-7075-12-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350282/
https://www.ncbi.nlm.nih.gov/pubmed/25745505
http://dx.doi.org/10.1186/1743-7075-12-1

Ejemplares similares